Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Diffuse Large B-Cell Lymphoma with Primary Treatment Failure: Identification of Ultra-High Risk Patients and Benchmarking for Experimental Therapies

Blood (2016) 128 (22): 103.

https://doi.org/10.1182/blood.V128.22.103.103

Published: 2016

Journal Articles

Osteocyte Apoptosis Attracts Myeloma Cells to Bone and Supports Progression through Regulation of the Bone Marrow Microenvironment

Timothy N. Trotter, Mary Fok, Justin T. Gibson, Deniz Peker, MD, Amjad Javed, MSc, PhD, Yang Yang, MD PhD

Blood (2016) 128 (22): 484.

https://doi.org/10.1182/blood.V128.22.484.484

Published: 2016

Journal Articles

Early Allogeneic Stem Cell Transplantation and Use of Asparaginase during Induction Chemotherapy Appear to Improve Otherwise Poor Outcomes in Adult T-Cell Acute Lymphoblastic Leukemia/Lymphoma (T-ALL/T-LBL) Patients: A Multi-Institutional Review

Uma Borate, MD, Amanda Redden Hathaway, MD, Deniz Peker, MD, Bradford E Jackson, PhD, Vamsi K Kota, MD, Bijal D Shah, Ling Zhang, MD, Anand Jillella, MD, Martha Arellano, MD, Leonard T. Heffner, MD, Harry P Erba, MD PhD

Blood (2015) 126 (23): 4869.

https://doi.org/10.1182/blood.V126.23.4869.4869

Published: 2015

Journal Articles

Multi-Institution Review of Adult Early T-Cell Precursor Acute Lymphoblastic Leukemia/Lymphoma (ETP-ALL)

Bijal D. Shah, MD, Uma Borate, MD, Vamsi K Kota, MD, Ling Zhang, MD, Deniz Peker, MD, Amanda Redden Hathaway, MD, Julio C Chavez, MD

Blood (2015) 126 (23): 3715.

https://doi.org/10.1182/blood.V126.23.3715.3715

Published: 2015

Journal Articles

Poor Outcomes with Hyper CVAD Induction for T-Cell Lymphoblastic Leukemia/Lymphoma

Vamsi K Kota, MD, Amanda Redden Hathaway, MD, Bijal D. Shah, MD, Deniz Peker, MD, Ling Zhang, MD, David L. Jaye, MD, Martha Arellano, MD, H Jean Khoury, Anand P Jillella, MD, Elliott F. Winton, MD, Leonard T Heffner, Jr., MD, Uma Borate, MD

Blood (2015) 126 (23): 3762.

https://doi.org/10.1182/blood.V126.23.3762.3762

Published: 2015

Journal Articles

The Role of Adipocyte Lineage Cells in Myeloma Growth and Dissemination in Bone

Timothy N Trotter, Tshering D Lama-Sherpa, Deniz Peker, MD, Amjad Javed, Larry J Suva, Yang Yang

Blood (2015) 126 (23): 1797.

https://doi.org/10.1182/blood.V126.23.1797.1797

Published: 2015

Journal Articles

Differences in Cell of Origin (COO) Affect Outcomes in Caucasian(C) but Not in African American(AA) Patients with Diffuse Large B-Cell Lymphoma(DLBCL)

Uma Borate, MD, Deniz Peker, MD, James M. Foran, MD, Luciano J Costa, MD PhD

Blood (2015) 126 (23): 1460.

https://doi.org/10.1182/blood.V126.23.1460.1460

Published: 2015

Journal Articles

Myeloma Cell-Derived Runx2 Promotes Myeloma Progression and Bone-Homing

Mei Li, PhD, Timothy N Trotter, BS, Deniz Peker, MD, Patrick D Rowan, BS, Pan Qianying, MD, Suva J. Larry, PhD, Amjad Javed, PhD, Yang Yang, MD PhD

Blood (2014) 124 (21): 724.

https://doi.org/10.1182/blood.V124.21.724.724

Published: 2014

Journal Articles

Heparanase Promotes Myeloma Metastasis By Inducing EMT-like Features in Both Myeloma Cells and Endothelial Cells

Qianying Pan, MD, Patrick D Rowan, BS, Racquel Innis-Shelton, MD, Timothy N Trotter, BS, Mei Li, PhD, Deniz Peker, MD, Larry J Suva, PhD, Yang Yang, MD PhD

Blood (2014) 124 (21): 2025.

https://doi.org/10.1182/blood.V124.21.2025.2025

Published: 2014

Journal Articles

Therapy-Related Myeloid Sarcoma As a New Diagnostic Entity? A 10-Year Institutional Retrospective Review

Taylor Deal, MD, Uma Borate, MD, Shuko Harada, MD, Vishnu Reddy, MD, Deniz Peker, MD

Blood (2013) 122 (21): 2656.

https://doi.org/10.1182/blood.V122.21.2656.2656

Published: 2013

Journal Articles

A Comparison of Prognostic Models for Chronic Myelomonocytic Leukemia (CMML) in the Era of Hypomethylating Agents

Eric Padron, MD, Najla H Al Ali, Deniz Peker, MD, Jeffrey E Lancet, MD, Pearlie K Epling-Burnette, PhD, Ling Zhang, MD, Alan F. List, MD, Rami S. Komrokji, MD

Blood (2012) 120 (21): 1695.

https://doi.org/10.1182/blood.V120.21.1695.1695

Published: 2012

Journal Articles

Hypomethylating Agents Improve Overall Survival in Higher Risk Chronic Myelomonocytic Leukemia (CMML)

Eric Padron, MD, Najla H Al Ali, Deniz Peker, MD, Jeffrey E Lancet, MD, P.K. Epling-Burnette, PharmD, PhD, Ling Zhang, MD, Alan F. List, MD, Rami S. Komrokji, MD

Blood (2012) 120 (21): 3838.

https://doi.org/10.1182/blood.V120.21.3838.3838

Published: 2012

Journal Articles

Double and Triple Hit Diffuse Large B Cell Lymphomas and First Line Therapy

Michael V. Jaglal, MD, Deniz Peker, MD, Jianguo Tao, MD, PhD, Jennifer L. Cultrera, MD

Blood (2012) 120 (21): 4885.

https://doi.org/10.1182/blood.V120.21.4885.4885

Published: 2012

Journal Articles

A Close Association of History of Autoimmunity with Chronic Myelomonocytic Leukemia (CMML) in Contrast to Chronic Myelogenous Leukemia (CML)

Deniz Peker, MD, Eric Padron, MD, Pedro Horna, MD, John M. Bennett, MD, Xiaohui Zhang, MD, P.K. Epling-Burnette, PharmD, PhD, Jeffrey E Lancet, MD, Javier Pinilla, Lynn Moscinski, MD, Alan F. List, MD, Rami S. Komrokji, MD, Ling Zhang, MD

Blood (2012) 120 (21): 1712.

https://doi.org/10.1182/blood.V120.21.1712.1712

Published: 2012

Journal Articles

Clinicohistologic Assessment of Bone Marrow Engraftment In Patients with Hematologic Malignancies Received Double Umbilical Cord Blood Transplantation – A Single Institutional Observation

Deniz Peker, MD, Marcie Tomblyn, MD, MS, Taiga Nishihori, MD, Elizabeth M. Sagatys, MD, Kaaron Benson, MD, Xiaohui Zhang, Lynn Moscinski, MD, Ling Zhang, MD

Blood (2011) 118 (21): 4578.

https://doi.org/10.1182/blood.V118.21.4578.4578

Published: 2011

Journal Articles

Clinicopathological Characteristics and Clinical Course of CD8 Expressing Primary Cutaneous Peripheral T-Cell Lymphomas (CTCL) - Retrospective Case Study

Deniz Peker, MD, Yizhou Zhang, Young Yu, Zhigang Zhao, Yafei Wang, Hongliang Yang, Frank Glass, Lynn Moscinski, MD, Lubomir Sokol, MD, PhD, Ling Zhang, MD

Blood (2011) 118 (21): 5213.

https://doi.org/10.1182/blood.V118.21.5213.5213

Published: 2011

Journal Articles

Morphologic and Phenotypic Features of Concurrent Clonal T-Cell Large Granular Lymphocytic Expansion and Myelodysplastic Syndrome

Xiaohui Zhang, Lynn Moscinski, MD, John M. Bennett, MD, Reza Setoodeh, MD, Deniz Peker, MD, Ling Zhang, MD

Blood (2011) 118 (21): 2803.

https://doi.org/10.1182/blood.V118.21.2803.2803

Published: 2011

NARROW

Diffuse Large B-Cell Lymphoma with Primary Treatment Failure: Identification of Ultra-High Risk Patients and Benchmarking for Experimental Therapies

Osteocyte Apoptosis Attracts Myeloma Cells to Bone and Supports Progression through Regulation of the Bone Marrow Microenvironment

Early Allogeneic Stem Cell Transplantation and Use of Asparaginase during Induction Chemotherapy Appear to Improve Otherwise Poor Outcomes in Adult T-Cell Acute Lymphoblastic Leukemia/Lymphoma (T-ALL/T-LBL) Patients: A Multi-Institutional Review

Multi-Institution Review of Adult Early T-Cell Precursor Acute Lymphoblastic Leukemia/Lymphoma (ETP-ALL)

Poor Outcomes with Hyper CVAD Induction for T-Cell Lymphoblastic Leukemia/Lymphoma

The Role of Adipocyte Lineage Cells in Myeloma Growth and Dissemination in Bone

Differences in Cell of Origin (COO) Affect Outcomes in Caucasian(C) but Not in African American(AA) Patients with Diffuse Large B-Cell Lymphoma(DLBCL)

Myeloma Cell-Derived Runx2 Promotes Myeloma Progression and Bone-Homing

Heparanase Promotes Myeloma Metastasis By Inducing EMT-like Features in Both Myeloma Cells and Endothelial Cells

Therapy-Related Myeloid Sarcoma As a New Diagnostic Entity? A 10-Year Institutional Retrospective Review

A Comparison of Prognostic Models for Chronic Myelomonocytic Leukemia (CMML) in the Era of Hypomethylating Agents

Hypomethylating Agents Improve Overall Survival in Higher Risk Chronic Myelomonocytic Leukemia (CMML)

Double and Triple Hit Diffuse Large B Cell Lymphomas and First Line Therapy

A Close Association of History of Autoimmunity with Chronic Myelomonocytic Leukemia (CMML) in Contrast to Chronic Myelogenous Leukemia (CML)

Clinicohistologic Assessment of Bone Marrow Engraftment In Patients with Hematologic Malignancies Received Double Umbilical Cord Blood Transplantation – A Single Institutional Observation

Clinicopathological Characteristics and Clinical Course of CD8 Expressing Primary Cutaneous Peripheral T-Cell Lymphomas (CTCL) - Retrospective Case Study

Morphologic and Phenotypic Features of Concurrent Clonal T-Cell Large Granular Lymphocytic Expansion and Myelodysplastic Syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only